Chemoresistance in human ovarian cancer: the role of apoptotic regulators - Test2 - elhamkhani - TriplyDB

Chemoresistance in human ovarian cancer: the role of apoptotic regulators

Chemoresistance in human ovarian cancer: the role of apoptotic regulators

http://www.wikidata.org/entity/Q24791433

about

Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity Phytoestrogen biological actions on Mammalian reproductive system and cancer growth Non-invasive imaging of phosphoinositide-3-kinase-catalytic-subunit-alpha (PIK3CA) promoter modulation in small animal models Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids Separation and identification of differentially expressed nuclear matrix proteins in breast carcinoma forming.miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines.MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1 Hsp90 inhibitor SY-016 induces G2/M arrest and apoptosis in paclitaxel-resistant human ovarian cancer cells The multiple facets of drug resistance: one history, different approaches.HtrA1 sensitizes ovarian cancer cells to cisplatin-induced cytotoxicity by targeting XIAP for degradation.Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine.Phytochemicals: a multitargeted approach to gynecologic cancer therapy.RSF1 is a positive regulator of NF-κB-induced gene expression required for ovarian cancer chemoresistance.Secreted frizzled-related protein 4 expression is positively associated with responsiveness to cisplatin of ovarian cancer cell lines in vitro and with lower tumour grade in mucinous ovarian cancers Ovarian cancer stem cells and inflammation P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism.Human GM3 Synthase Attenuates Taxol-Triggered Apoptosis Associated with Downregulation of Caspase-3 in Ovarian Cancer Cells.Human beta-galactoside alpha-2,3-sialyltransferase (ST3Gal III) attenuated Taxol-induced apoptosis in ovarian cancer cells by downregulating caspase-8 activity.Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis Expression of peroxisome proliferator activated receptor gamma and cyclo-oxygenase 2 in primary and recurrent ovarian carcinoma.Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth Ovarian cancer metastasis: integrating insights from disparate model organisms.Dual Targeting of mTOR Activity with Torin2 Potentiates Anticancer Effects of Cisplatin in Epithelial Ovarian Cancer RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer.Effect of Chemotherapeutic Drugs on Caspase-3 Activity, as a Key Biomarker for Apoptosis in Ovarian Tumor Cell Cultured as Monolayer. A Pilot Study.Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -a study of the OVCAD consortium Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance.Resistance to chemotherapy in cancer: a complex and integrated cellular response.Enhancement of cisplatin-induced apoptosis by β-elemene in resistant human ovarian cancer cells DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma.Piceatannol enhances cisplatin sensitivity in ovarian cancer via modulation of p53, X-linked inhibitor of apoptosis protein (XIAP), and mitochondrial fission Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity.Future directions in the management of epithelial ovarian cancer.Mifepristone abrogates repopulation of ovarian cancer cells in between courses of cisplatin treatment Oligodendrocyte/type-2 astrocyte progenitor cells and glial-restricted precursor cells generate different tumor phenotypes in response to the identical oncogenes.Microenvironment mesenchymal cells protect ovarian cancer cell lines from apoptosis by inhibiting XIAP inactivation An Acetamide Derivative as a Camptothecin Sensitizer for Human Non-Small-Cell Lung Cancer Cells through Increased Oxidative Stress and JNK Activation.

P2860

Q24547477-5E31F8B9-21B6-4A18-A15A-7790D3DC6B05 Q24633150-D6B86C73-2EE1-4489-A626-A15BA2975F10 Q28485978-A5AB9D65-6A19-430F-9F61-8FDC1B62E893 Q30541218-FCEA522F-38AC-4A05-AC66-86C83DABF6F1 Q33321330-25DD5063-A6B0-4251-A669-F712B3917F45 Q33514072-00FE804C-859D-4E25-B040-356F74660D75 Q33530333-23BC9312-540D-48F9-AF79-EC1242497475 Q33587320-172E9C6A-CE89-4F3A-85B2-BD9F2D249025 Q33598733-E00F4E6E-B643-465D-9FEF-E8933ABEF53D Q33697116-CFD32E09-123C-4E0E-9740-45F6C0C2733F Q33841141-12A443D5-8060-4153-8511-9FA2D062C8DF Q33896588-43A7BE14-2504-47DE-AA9F-5491C7FFC579 Q33908881-083087D4-1CE0-423A-8F4B-D55A7E9309A2 Q34406586-F1366F66-F057-44A3-BDAC-CF1149ADEC22 Q34435134-D45CC064-C694-49F4-84F3-74892F65B2C1 Q35001138-45F7AB32-C9E0-4AE7-96A4-ADB0A07874CE Q35359342-4572CEA4-C09E-4D3B-A318-B25E25D08298 Q35445963-09CCF250-CCE3-489B-B478-76C76F8BDD61 Q35668911-62228D13-D184-4C2B-91CE-E9FF68741460 Q35737753-96A9BB53-91AE-419D-8507-5DB9BBEFC6E4 Q35770556-48AE9BFC-43F4-4372-8955-ED7A4E5C4A37 Q36011433-34F6C954-1865-4FC2-A8EE-924B8C107469 Q36111930-2C09CFB7-B05D-411A-AA97-C79974C14980 Q36167088-5851E5F7-C2F6-43E8-BD3D-6EA33C9E2E71 Q36308299-BE5EE903-9627-455D-BF62-7762DB9C9AD5 Q36358405-BF6A9F46-CD67-411F-8CB2-AA6299CB4CFF Q36403630-76A1915B-2FE1-43C1-925B-26D94E0C8999 Q36414284-78E26E59-E96C-4B2C-83D7-E5AD62B50CB7 Q36498614-E190B8D3-1274-4CAD-892A-E1196037A6FB Q36696532-37741E63-5ED6-4AB5-AC62-9527A157B8E8 Q37079652-199B733B-2358-4022-A6E2-3237171D819E Q37080469-102CF742-B0D0-4980-BDC6-BFFE0355D504 Q37097138-D386E7A5-9DAA-4B43-9F15-93B8102A6150 Q37099682-F382EEF6-56C2-403B-81F7-7D4CCD96D33C Q37140728-B79C7A5D-E20F-4179-840A-D41DE8B4DEA6 Q37179400-5FD160B1-9AF0-41AC-BE6B-A7A43A249493 Q37213050-07AB937F-B39D-41B4-8BE5-FFF813B8995D Q37231529-8F8BE6AE-6989-4352-BFB6-B441F5C8532C Q37299698-6613BE46-21C9-4F3A-942A-1AD0DCCDC1FC Q37397101-267EE184-4947-4C78-90CD-C3B892E26BA4

P2860

Chemoresistance in human ovarian cancer: the role of apoptotic regulators

http://www.wikidata.org/entity/Q24791433

description

2003 nî lūn-bûn

@nan

2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Chemoresistance in human ovarian cancer: the role of apoptotic regulators

@ast

Chemoresistance in human ovarian cancer: the role of apoptotic regulators

@en

Chemoresistance in human ovarian cancer: the role of apoptotic regulators

@nl

type

label

Chemoresistance in human ovarian cancer: the role of apoptotic regulators

@ast

Chemoresistance in human ovarian cancer: the role of apoptotic regulators

@en

Chemoresistance in human ovarian cancer: the role of apoptotic regulators

@nl

prefLabel

Chemoresistance in human ovarian cancer: the role of apoptotic regulators

@ast

Chemoresistance in human ovarian cancer: the role of apoptotic regulators

@en

Chemoresistance in human ovarian cancer: the role of apoptotic regulators

@nl

P1433

Q24791433-4DB16826-B882-4BE3-9567-94E872E96E16

P1476

Q24791433-A04141DD-B6B1-41CF-88C6-5D241E30DFDF

P2093

Q24791433-1796E98E-3674-450E-B2FB-C007EB7FB3A7

Q24791433-45591C32-29C9-465A-A2A3-198A4C90366D

Q24791433-481D63C6-398A-4760-B489-581579D279EB

Q24791433-4E24CF29-9065-4B9E-8090-80C34B50CE53

Q24791433-96B7B0EB-C242-4556-8F48-5F67E9D79658

P2860

Q24791433-0094BE81-179E-4B73-A41C-AD9EA73B9750

Q24791433-01E2B685-2F5C-423D-A75F-DBAA9B4D4B0D

Q24791433-0749B9B0-CAE6-4B15-98A4-5524363D8717

Q24791433-08949DF1-B26B-4524-8857-30F813C92172

Q24791433-0C9BFD17-A98E-43CC-8255-893BB4A30A9D

Q24791433-0F073D07-8B9E-4760-ADBB-9EC99F25B007

Q24791433-193883B3-2455-465B-B959-9AA2FACC6A5B

Q24791433-1DB9B90D-0ECB-43D4-A7D5-D42F12A89310

Q24791433-2312EE47-ED0B-439B-A95D-EB922C10832A

Q24791433-25766F7B-1957-416E-9290-755E917C3493

P2888

Q24791433-C7E361BE-3337-49F2-BE5F-54482DC025C3

P304

Q24791433-4341C077-4F70-4977-83F7-6B2A8D2F81E4

P31

Q24791433-BC47E15E-2E43-47D1-B779-4BEAECEC6FD2

P3181

Q24791433-8BBF1A1B-AF16-460F-8433-0B18CC6FD962

P356

Q24791433-106751FB-F093-40C1-9F0F-CC6FB054D4B7

P407

Q24791433-EE42EDCE-6733-40A9-8D97-957AC408FDBA

P433

Q24791433-DDF9E397-B7D7-460C-8E58-5FA58D7FA1FB

P478

Q24791433-FD511A3B-D53F-4396-9524-DD703125A993

P50

Q24791433-500173D8-638E-4210-9511-83A6B54448A7

P577

Q24791433-353F2789-87F9-4D0A-BBF8-752CFAC49FAF

P5875

Q24791433-3940BFD4-B05E-4575-9E4B-10E0C697A525

P6179

Q24791433-7D7EA4F1-AFFB-423A-B8E5-F51E9E10BFFC

P698

Q24791433-7D6C3F38-A21C-4F17-8674-D19B867C8E14

P921

Q24791433-04316B73-A13C-49A7-8B82-AB378FE9BCBA

Q24791433-2664D28B-7792-4EED-AF48-27DB6A676F25

Q24791433-4C2B2E7B-43F2-4B30-A9DA-C8026EA7EF56

Q24791433-5920BD9B-4E9C-4D9F-BA6B-3FEB0B347973

Q24791433-DF718966-83A5-4784-B4B9-3FF15A889919

P932

Q24791433-92F27918-33B1-4432-9BB6-457DB0AFB429

P3181

P356

P1433

Reproductive Biology and Endocrinology

P1476

Chemoresistance in human ovarian cancer: the role of apoptotic regulators

@en

P2093

Arezu Jahani-Asl

http://www.w3.org/2001/XMLSchema#string

Brendan Leung

http://www.w3.org/2001/XMLSchema#string

Michael Fraser

http://www.w3.org/2001/XMLSchema#string

Winston E Thompson

http://www.w3.org/2001/XMLSchema#string

Xiaojuan Yan

http://www.w3.org/2001/XMLSchema#string

P2860

Ubiquitination of prohibitin in mammalian sperm mitochondria: possible roles in the regulation of mitochondrial inheritance and sperm quality control

IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition.

Prohibitin requires Brg-1 and Brm for the repression of E2F and cell growth.

Mechanism of activation of protein kinase B by insulin and IGF-1

Inhibition of death receptor signals by cellular FLIP

Growth suppression by p16ink4 requires functional retinoblastoma protein

A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor

X-linked IAP is a direct inhibitor of cell-death proteases

The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest

Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

P2888

P304

66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2823440

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1477-7827-1-66

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Benjamin K Tsang

P577

2003-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9016844

http://www.w3.org/2001/XMLSchema#string

P6179

1023150314

http://www.w3.org/2001/XMLSchema#string

P698

14609433

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

reproductive medicine

physiological phenomena

P932

270001

http://www.w3.org/2001/XMLSchema#string